Holen Sie sich die Stockscreener-App
12.68
0.94%
-0.12
Handel nachbörslich:
13.01
0.33
+2.60%
Schlusskurs vom Vortag:
$12.80
Offen:
$13.16
24-Stunden-Volumen:
2.10M
Relative Volume:
0.32
Marktkapitalisierung:
$2.36B
Einnahmen:
$93.95M
Nettoeinkommen (Verlust:
$-129.87M
KGV:
-14.09
EPS:
-0.9
Netto-Cashflow:
$-202.88M
1W Leistung:
-5.72%
1M Leistung:
-10.83%
6M Leistung:
+44.75%
1J Leistung:
+17.41%
1-Tages-Spanne:
$12.54
$13.16
1-Wochen-Bereich:
$12.51
$14.15
52-Wochen-Spanne:
$5.28
$21.73
Wave Life Sciences Ltd Stock (WVE) Company Profile
Firmenname
Wave Life Sciences Ltd
Sektor
Branche
Telefon
617-949-2900
Adresse
7 STRAITS VIEW, SINGAPORE
Compare WVE vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
WVE
Wave Life Sciences Ltd
|
12.68 | 2.38B | 93.95M | -129.87M | -202.88M | -0.90 |
|
VRTX
Vertex Pharmaceuticals Inc
|
491.47 | 117.98B | 12.04B | 3.95B | 3.34B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
803.17 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
821.96 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.40 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.07 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-05 | Eingeleitet | BofA Securities | Buy |
| 2025-12-12 | Bestätigt | Wedbush | Outperform |
| 2025-12-09 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-10-20 | Eingeleitet | Wells Fargo | Overweight |
| 2025-08-04 | Eingeleitet | Canaccord Genuity | Buy |
| 2025-07-28 | Eingeleitet | Oppenheimer | Outperform |
| 2025-07-16 | Eingeleitet | Citigroup | Buy |
| 2025-06-11 | Fortgesetzt | Raymond James | Outperform |
| 2025-04-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-04-08 | Eingeleitet | Wedbush | Outperform |
| 2025-02-25 | Eingeleitet | Jefferies | Buy |
| 2024-10-16 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-09-27 | Fortgesetzt | JP Morgan | Overweight |
| 2024-09-19 | Eingeleitet | B. Riley Securities | Buy |
| 2024-09-09 | Eingeleitet | JP Morgan | Overweight |
| 2024-05-15 | Eingeleitet | Wells Fargo | Overweight |
| 2023-12-19 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2023-07-05 | Eingeleitet | Raymond James | Outperform |
| 2023-05-24 | Herabstufung | Jefferies | Buy → Hold |
| 2020-12-15 | Fortgesetzt | H.C. Wainwright | Buy |
| 2020-10-23 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2019-12-31 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2019-11-01 | Eingeleitet | Guggenheim | Buy |
| 2019-07-15 | Eingeleitet | Cowen | Market Perform |
| 2019-04-17 | Bestätigt | H.C. Wainwright | Buy |
| 2018-08-07 | Eingeleitet | Stifel | Buy |
| 2018-07-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-03-19 | Bestätigt | Mizuho | Buy |
| 2017-02-15 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-11-10 | Fortgesetzt | Leerink Partners | Outperform |
| 2015-12-07 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2015-12-07 | Eingeleitet | Jefferies | Buy |
| 2015-12-07 | Eingeleitet | Leerink Partners | Outperform |
| 2015-12-07 | Eingeleitet | Sun Trust Rbsn Humphrey | Buy |
Alle ansehen
Wave Life Sciences Ltd Aktie (WVE) Neueste Nachrichten
Can Wave Life Sciences Ltd. stock deliver surprise earnings beatJuly 2025 Institutional & Entry Point Confirmation Signals - mfd.ru
WAVE Life Sciences (NASDAQ:WVE) Given New $27.00 Price Target at Wells Fargo & Company - MarketBeat
WVE Stock Update: Wells Fargo Adjusts Price Target Amidst Steady - GuruFocus
Paul Bolno Sells 10,480 Shares of WAVE Life Sciences (NASDAQ:WVE) Stock - MarketBeat
Insider Selling: WAVE Life Sciences (NASDAQ:WVE) Insider Sells 1,883 Shares of Stock - MarketBeat
Insider Selling: WAVE Life Sciences (NASDAQ:WVE) Insider Sells 3,228 Shares of Stock - MarketBeat
Is Wave Life Sciences Ltd. stock supported by strong cash flowsJuly 2025 Recap & Technical Pattern Recognition Alerts - mfd.ru
(02/11/26) Top Picks 2026: Wave Life Sciences Ltd. (WVE) - moneyshow.com
Published on: 2026-02-10 01:59:11 - baoquankhu1.vn
Wave Life Sciences (WVE) regains rights to potential rare genetic disorder treatment - MSN
The Bull Case For Wave Life Sciences (WVE) Could Change Following WVE-006 Rights Reversion And FDA Talks - Yahoo Finance
Assessing Wave Life Sciences (WVE) Valuation After A 7x Three Year Total Return - Yahoo Finance
Why The Wave Life Sciences WVE Story Is Shifting After New RNA And AATD Updates - Yahoo Finance
Will Regaining Full Rights to WVE-006 and Pursuing FDA Fast Track Change Wave Life Sciences' (WVE) Narrative - simplywall.st
How (WVE) Movements Inform Risk Allocation Models - Stock Traders Daily
Wave Life Sciences (WVE) Regains Rights to Potential Rare Genetic Disorder Treatment - Finviz
WAVE Life Sciences (NASDAQ:WVE) Downgraded by Wall Street Zen to "Sell" - MarketBeat
Wave Life Sciences receives back rights to AATD therapy from GSK - MSN
13 Best Revenue Growth Stocks to Buy Right Now - Insider Monkey
WAVE Life Sciences (NASDAQ:WVE) Stock Price Expected to Rise, Cantor Fitzgerald Analyst Says - MarketBeat
WAVE Life Sciences (NASDAQ:WVE) Now Covered by Bank of America - MarketBeat
WVE Sees Analyst Rating Boost with Raised Price Target | WVE Stock News - GuruFocus
Assessing Wave Life Sciences (WVE) Valuation After Regaining Global Rights To WVE-006 From GSK - simplywall.st
Analysts Offer Insights on Healthcare Companies: Atricure (ATRC), Wave Life Sciences (WVE) and Arcellx Inc (ACLX) - The Globe and Mail
Wave Life Sciences Ltd. (WVE): Analyst Consensus Highlights 143.73% Potential Upside for Biotech Innovator - DirectorsTalk Interviews
Wave Life Sciences price target raised to $50 from $47 at Clear Street - Yahoo Finance
WVE Sees Price Target Boost: Canaccord Genuity Adjusts to $43.00 - GuruFocus
Wave Life Sciences Regains Full Rights to WVE-006 from GSK - intellectia.ai
WAVE Life Sciences stock price target raised to $43 from $40 at Canaccord - Investing.com Australia
WAVE Life Sciences stock rating reiterated at Buy by H.C. Wainwright - Investing.com India
Wave Life Sciences regains rights to AATD therapy WVE-006 from GSK - Investing.com Nigeria
Wave Life Sciences regains rights to AATD therapy WVE-006 from GSK By Investing.com - Investing.com South Africa
WAVE Life Sciences stock rating reiterated by Raymond James on regained drug rights - Investing.com Australia
Wave Life Sciences Reclaims Rare Disease Drug From GSK, Targets Faster FDA Path - Benzinga
Clear Street raises WAVE Life Sciences stock price target to $50 on AATD program - Investing.com Nigeria
Wave Life Sciences stock rises after regaining full rights to AATD therapy By Investing.com - Investing.com South Africa
Wave Life Sciences stock rises after regaining full rights to AATD therapy - Investing.com India
Wave Life Sciences (WVE) Reclaims Rights to AATD Asset WVE-006 - GuruFocus
Wave Life Sciences plans to accelerate regulatory engagement with full control of WVE-006 - marketscreener.com
Wave Life Sciences Regains WVE-006 Rights, Plans Accelerated Path - TipRanks
Wave Life Sciences Announces Plans to Accelerate Regulatory Engagement with Full Control of WVE-006 for Alpha-1 Antitrypsin Deficiency - The Manila Times
Wave Life Sciences Ltd Accelerates Regulatory Engagement for WVE-006 - TradingView
Wave RNA drug for rare lung and liver disease heads for FDA talks - Stock Titan
How Investors May Respond To Wave Life Sciences (WVE) Expanding PRISM RNA Platform Via Big-Pharma Partnerships - Sahm
Market Outlook: Does CBTJ stock reflect fundamentalsJuly 2025 Volume & High Accuracy Investment Entry Signals - baoquankhu1.vn
Federated Hermes Inc. Has $27.46 Million Position in WAVE Life Sciences Ltd. $WVE - MarketBeat
WAVE Life Sciences (NASDAQ:WVE) Stock Passes Below 50-Day Moving AverageShould You Sell? - MarketBeat
Wave Life Sciences Ltd. (WVE) Growth Potential: Analysts Predict 141% Upside - DirectorsTalk Interviews
Trading Systems Reacting to (WVE) Volatility - Stock Traders Daily
Aug Outlook: Will Standard BioTools Inc stock recover after earningsPortfolio Growth Summary & Fast Entry High Yield Tips - baoquankhu1.vn
Buyback Watch: Will Wave Life Sciences Ltd outperform small cap indexes2025 Technical Patterns & Weekly Breakout Stock Alerts - baoquankhu1.vn
Finanzdaten der Wave Life Sciences Ltd-Aktie (WVE)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.12%
0.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):